Drugpharm (Pvt) Ltd Recalls Pabrine Tablets — Batch PO4 (Reg. #006250, Exp. 12-2028)
Drugpharm (Pvt) Ltd Recalls Pabrine Tablets · Lahore · The Express Tribune,
Notice advertisement published in The Express Tribune on Saturday, 25 July 2026, listed under Lahore. Issued by Drugpharm (Pvt) Ltd Recalls Pabrine Tablets.
The original image is temporarily unavailable. Use the source link or the details below. Open the full-size clipping Advertisement details
Issuer: M/S Drugpharm (Pvt) Ltd — Precautionary recall notice addressed to doctors, pharmacists, hospitals, distributors, wholesalers, retailers, chemists and patients.
Purpose: Precautionary recall of a specific batch of Pabrine Tablets. Recipients are requested to stop use and isolate stocks of the affected batch.
| Product | Registration # | Batch # | Expiry | Scope |
|---|---|---|---|---|
| Pabrine Tablets | 006250 | PO4 | 12-2028 | Recall is specific to Batch PO4 only |
Notes: The recall is described as precautionary following internal quality testing. Health professionals and patients should cease use of the listed batch and secure remaining stock of that batch.
Contact for further information: M/S Drugpharm (Pvt) Ltd, 28 KM Lahore Sheikhapura Road, Lahore. Phone: 0329 7000223.
Published in The Express Tribune on Saturday, 25 July 2026. DailyAds.pk indexes newspaper advertisements; the original notice and the issuing organisation remain the source for final terms and eligibility.
Questions about this notice
- What is the last date for this notice?
- This advertisement prints no last date. Read the clipping and confirm with Drugpharm (Pvt) Ltd Recalls Pabrine Tablets.
- Which newspaper published this notice?
- The Express Tribune, in the edition of Saturday, 25 July 2026.
- Which city is this notice listed under?
- Lahore. That is the city recorded for this advertisement — taken from the notice where it names a place, and otherwise from the newspaper edition it appeared in.
- How do I respond to this notice?
- Follow the instructions printed in the clipping; the advertiser’s own page is linked from this one. Applications are not submitted through this page.